Trials / Withdrawn
WithdrawnNCT00486980
Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAMUSCULAR PERAMIVIR IN SUBJECTS WITH UNCOMPLICATED ACUTE INFLUENZA
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- BioCryst Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is a multinational, randomized, double-blind study comparing the efficacy and safety of two single dose regimens of peramivir administered intramuscularly versus placebo in adults with uncomplicated acute influenza.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Peramivir 150mg | |
| DRUG | Peramivir 300mg |
Timeline
- First posted
- 2007-06-15
- Last updated
- 2008-01-30
Source: ClinicalTrials.gov record NCT00486980. Inclusion in this directory is not an endorsement.